GlobeNewswire Inc. · Nov 26, 2024
ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights
ONWARD Medical raised €50 million in new capital, signed an exclusive license with CEA for WIMAGINE Brain-Computer Interface, and appointed Rob ten Hoedt as the new Board Chairman. The company is preparing for the commercialization of its ARC-EX System and conducting clinical studies for its ARC-IM and ARC-BCI therapies.

